<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EF4AABCF-1459-46A0-A0CC-C9C310A5DF2A"><gtr:id>EF4AABCF-1459-46A0-A0CC-C9C310A5DF2A</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Weinman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/81DAB9D5-DD29-4F54-9B96-8A8B893F0115"><gtr:id>81DAB9D5-DD29-4F54-9B96-8A8B893F0115</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Armstrong</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/46F9DB7E-4379-4950-94C7-F8B44FF3CA8F"><gtr:id>46F9DB7E-4379-4950-94C7-F8B44FF3CA8F</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Sutton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/94186691-E7FD-4DA9-928F-ED26535A07BB"><gtr:id>94186691-E7FD-4DA9-928F-ED26535A07BB</gtr:id><gtr:firstName>Theresa Mary</gtr:firstName><gtr:surname>Marteau</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BA3CAF6A-D534-4763-8317-FCC2FC5C4B6A"><gtr:id>BA3CAF6A-D534-4763-8317-FCC2FC5C4B6A</gtr:id><gtr:firstName>Toby</gtr:firstName><gtr:surname>Prevost</gtr:surname><gtr:orcidId>0000-0003-1723-0796</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/976F6B3B-EFBC-4874-A746-3776C9997384"><gtr:id>976F6B3B-EFBC-4874-A746-3776C9997384</gtr:id><gtr:firstName>Ann</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Kinmonth</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500274"><gtr:id>5E0D929A-0CA2-489D-9263-DDB8F0F0BAC3</gtr:id><gtr:title>Risk communication in preventive medicine: Optimising the impact of DNA risk information</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500274</gtr:grantReference><gtr:abstractText>Summary
There is growing interest in how genetic information might be used to motivate people to change their behaviour to reduce their risks of disease. But the few studies available show few motivating effects. Moreover, genetic information on risk may have perverse behavioural consequences if negative test results reduce engagement in health-directed behaviours. Given the personal nature of genetic information it should have potential to be more motivating than other types of risk information, particularly if it is presented in a way that makes sense to people given their existing ideas about genes and risk.

The aim of the proposed research is to explain how people respond to genetic risk information as a first step towards developing effective ways of communicating such information.

Three linked studies will be conducted. Two assess the risk of developing diseases in at risk populations (Crohn?s disease and cardiovascular disease). The third study assesses the risk of responding well to different types of prescription for a medicine (nicotine replacement therapy, being prescribed for smokers attempting to stop). In each study people have a risk assessment based either on assessing their genes or assessing another type of risk indicator. In each study people will be told what they can do to reduce their risks of disease (Studies 1 and 2) or increase the chances that their medicine will work (Study 3).

Relevance
Rapid developments in medicine and particularly genetics make it increasingly possible to predict preventable diseases. For this to lead to health improvements the information needs to be communicated to motivate people to relevant actions. The proposed research aims to understand, from the recipients? perspectives, how they make sense of genetic risk information and how this affects their subsequent behaviour. 

Translation for the general public
A core feature of the proposed research is to learn how people make sense of genetic information on risk. The results of the research are intended to help doctors and other health professionals to communicate this information effectively both to those undergoing genetic testing and to the public more generally. The general public will be represented, along with other key stakeholders, at one of two workshops that will be organised as part of the research, one at the planning stage, and one towards the end. In addition our dissemination strategy (see Section 6 of the protocol) involves direct communication with user groups including general public representatives.</gtr:abstractText><gtr:technicalSummary>Background
There is growing interest in using genetic risk information to motivate people to engage in risk-reducing behaviours. DNA risk information has the potential to be more motivating than other types of risk information given its personalized nature, yet only a few studies to date support this. Moreover there are concerns that DNA based risk assessments may have unintended harmful consequences if negative (low risk) test results reinforce engaging in health-risk behaviours. We propose a novel integration of two models of health related behaviour (Protection Motivation Theory and Leventhal?s Self Regulation Model of Health and Illness) to guide the presentation of DNA based risk assessments and to provide theory-based explanation and prediction of responses to risk assessments based on genotype and phenotype.

Aim
The aim of the proposed research is to describe systematically, behavioural responses to DNA risk information as a first step towards developing effective ways of communicating such information to realize its health benefits.

Methods
Three linked studies are proposed in which DNA risk information is used to predict clinically salient outcomes that are potentially modifiable in ways that require individuals to act. 

The experimental designs of the three studies are similar. Participants are randomly allocated to receive a risk assessment that either does or does not include a DNA test. Both qualitative and quantitative data are collected in each study. The studies differ in the participants involved, the type of risk assessments conducted and the behaviours indicated to reduce risk. In Study 1, smokers who are first degree relatives of patients with Crohn?s disease are informed how their identified risks of Crohn?s disease may be reduced by stopping smoking. In Study 2, first and second degree relatives of patients with Familial Hypercholesterolaemia are informed how their identified risks of cardiovascular disease may be reduced, by adhering to recommendations to take lipid lowering medication, alongside altering their diet and levels of physical activity, and if relevant, stopping smoking. In Study 3, following a risk assessment of responsiveness to nicotine replacement therapy (NRT), smokers are informed how their chances of stopping smoking may be enhanced by adhering to a tailored prescription of NRT.

Application
These timely and novel studies will form a basis for designing effective interventions aimed at facilitating behaviour change following the provision of a range of assessments of risk status, particularly those incorporating DNA based information, which will increasingly be used following such studies as Bio-bank.</gtr:technicalSummary><gtr:fund><gtr:end>2010-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1034036</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>738EB734-D947-49ED-BC6D-D8957A612F37</gtr:id><gtr:title>Patient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c90da9aad5cf7a7745a114e4e99690f1"><gtr:id>c90da9aad5cf7a7745a114e4e99690f1</gtr:id><gtr:otherNames>Hollands GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>pm_15044_24_22994377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73142E35-AE47-445E-9F09-5D571DD60643</gtr:id><gtr:title>Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6dccf135b9a077b6dca4f42e6bcc8f5"><gtr:id>a6dccf135b9a077b6dca4f42e6bcc8f5</gtr:id><gtr:otherNames>Lewis CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>pm_15044_14_17660460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C50AEC71-E256-47F4-9B18-016FEFA96BAD</gtr:id><gtr:title>Explaining behavior change after genetic testing: the problem of collinearity between test results and risk estimates.</gtr:title><gtr:parentPublicationTitle>Genetic testing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb1d0c1beba80ee5f9a370206df95780"><gtr:id>eb1d0c1beba80ee5f9a370206df95780</gtr:id><gtr:otherNames>Fanshawe TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1090-6576</gtr:issn><gtr:outcomeId>589FDE82A54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42BC6605-E664-4F7F-9DED-F9AEF951C8FA</gtr:id><gtr:title>Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8683458b2f0c5bc670fa3a9a4bb52d3"><gtr:id>c8683458b2f0c5bc670fa3a9a4bb52d3</gtr:id><gtr:otherNames>Whitwell SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>D705E400_CD705E400_C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04EB7205-40AD-4703-BC86-F78D3C608A66</gtr:id><gtr:title>Recruiting first-degree relatives for prevention research: a comparison of clinician and proband-led methods of contact in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0fcd9bc77a81cf28269626288dcd9dc"><gtr:id>e0fcd9bc77a81cf28269626288dcd9dc</gtr:id><gtr:otherNames>Reid EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>pm_15044_14_16868558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74BCD63A-B64D-4469-86F3-44F1F69727F1</gtr:id><gtr:title>Genetic unexceptionalism: clinician accounts of genetic testing for familial hypercholesterolaemia.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c9a9930424397a76e102f971a72b797"><gtr:id>5c9a9930424397a76e102f971a72b797</gtr:id><gtr:otherNames>Will CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>jdXfLzXErgM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46D45471-541E-41D3-BB60-812BE4E08834</gtr:id><gtr:title>Future health applications of genomics: priorities for communication, behavioral, and social sciences research.</gtr:title><gtr:parentPublicationTitle>American journal of preventive medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d4be7f923a0aab03e29742940b1e662"><gtr:id>7d4be7f923a0aab03e29742940b1e662</gtr:id><gtr:otherNames>McBride CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0749-3797</gtr:issn><gtr:outcomeId>PFHwF2J9c2r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FAF57B3-69C1-4A14-AFD7-AC77D80256A3</gtr:id><gtr:title>Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3db333fb521c8c3c45a690799005b0c"><gtr:id>b3db333fb521c8c3c45a690799005b0c</gtr:id><gtr:otherNames>Marteau TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>Y28NN3vHL1G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6409A00-9A28-4BB9-B78A-4704D8DD0304</gtr:id><gtr:title>Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c90da9aad5cf7a7745a114e4e99690f1"><gtr:id>c90da9aad5cf7a7745a114e4e99690f1</gtr:id><gtr:otherNames>Hollands GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_15044_24_22822007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F87D649-89A6-4B5D-9547-0EA48FBF5762</gtr:id><gtr:title>Cochrane Database of Systematic Reviews - Protocols</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1c957e85cfe7f64ca9c02e4741ff1b2"><gtr:id>d1c957e85cfe7f64ca9c02e4741ff1b2</gtr:id><gtr:otherNames>Marteau T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1996-01-01</gtr:date><gtr:outcomeId>doi_55f983983a6f0cf9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>363D2CB5-47E1-4861-9A88-F1F18A979C9F</gtr:id><gtr:title>The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c90da9aad5cf7a7745a114e4e99690f1"><gtr:id>c90da9aad5cf7a7745a114e4e99690f1</gtr:id><gtr:otherNames>Hollands GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>585d65bd44f6e8.89492941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECC56493-E388-44A1-BBFD-EE3B398DF184</gtr:id><gtr:title>Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3db333fb521c8c3c45a690799005b0c"><gtr:id>b3db333fb521c8c3c45a690799005b0c</gtr:id><gtr:otherNames>Marteau TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>XG2XYgwjsso</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAC2198B-EC67-4F6B-9B0A-72B491A4EB48</gtr:id><gtr:title>Impact of communicating personalized genetic risk information on perceived control over the risk: a systematic review.</gtr:title><gtr:parentPublicationTitle>Genetics in medicine : official journal of the American College of Medical Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1378b026e5d5e484b8a191ee87be03b"><gtr:id>b1378b026e5d5e484b8a191ee87be03b</gtr:id><gtr:otherNames>Collins RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1098-3600</gtr:issn><gtr:outcomeId>evE5GxzR4p4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CCCC8F6-46E7-4D9B-9ED1-8115639A97AD</gtr:id><gtr:title>The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d56874172530407edc42c7c3d798359d"><gtr:id>d56874172530407edc42c7c3d798359d</gtr:id><gtr:otherNames>Ware JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>5675e2bf93694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AC2AE97-3DB7-4186-9603-35E43A35A0D3</gtr:id><gtr:title>Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3914875f440967d10a9a47f45c71e74b"><gtr:id>3914875f440967d10a9a47f45c71e74b</gtr:id><gtr:otherNames>McDermott MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>pm_15044_24_23284151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75BB2E13-4910-410E-A4DB-659FE9BC5113</gtr:id><gtr:title>The impact of numeracy on reactions to different graphic risk presentation formats: An experimental analogue study.</gtr:title><gtr:parentPublicationTitle>British journal of health psychology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c0469fc5dc00695f27e3bbc4f71be88"><gtr:id>9c0469fc5dc00695f27e3bbc4f71be88</gtr:id><gtr:otherNames>Wright AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-107X</gtr:issn><gtr:outcomeId>A2B2E2430CC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E004F63-40E1-49E2-9CA5-120E0AA97161</gtr:id><gtr:title>Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care.</gtr:title><gtr:parentPublicationTitle>Nicotine &amp; tobacco research : official journal of the Society for Research on Nicotine and Tobacco</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c90da9aad5cf7a7745a114e4e99690f1"><gtr:id>c90da9aad5cf7a7745a114e4e99690f1</gtr:id><gtr:otherNames>Hollands GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1462-2203</gtr:issn><gtr:outcomeId>pm_540e140e1405611f0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA7EB881-FEE5-40A8-AD21-2DF524445FF6</gtr:id><gtr:title>The impact of genetic testing for Crohn's disease, risk magnitude and graphical format on motivation to stop smoking: an experimental analogue study.</gtr:title><gtr:parentPublicationTitle>Clinical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c0469fc5dc00695f27e3bbc4f71be88"><gtr:id>9c0469fc5dc00695f27e3bbc4f71be88</gtr:id><gtr:otherNames>Wright AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-9163</gtr:issn><gtr:outcomeId>AEFF6EE2972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54454507-9440-410C-94A8-6F1DDEEF709D</gtr:id><gtr:title>Why does genetic causal information alter perceived treatment effectiveness? An analogue study.</gtr:title><gtr:parentPublicationTitle>British journal of health psychology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c0469fc5dc00695f27e3bbc4f71be88"><gtr:id>9c0469fc5dc00695f27e3bbc4f71be88</gtr:id><gtr:otherNames>Wright AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1359-107X</gtr:issn><gtr:outcomeId>pm_15044_24_22107338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6352335-0CF0-4D63-9C8E-BE8931C3B69B</gtr:id><gtr:title>Emotional impact of screening: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1378b026e5d5e484b8a191ee87be03b"><gtr:id>b1378b026e5d5e484b8a191ee87be03b</gtr:id><gtr:otherNames>Collins RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>pm_15044_24_21798046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CC855BD-75A4-4752-9EA0-B3672A3E9D57</gtr:id><gtr:title>Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3db333fb521c8c3c45a690799005b0c"><gtr:id>b3db333fb521c8c3c45a690799005b0c</gtr:id><gtr:otherNames>Marteau TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15044_24_22509402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36F17211-3777-463A-8F96-5ADED6002AA3</gtr:id><gtr:title>Lack of association of OPRM1 genotype and smoking cessation.</gtr:title><gtr:parentPublicationTitle>Nicotine &amp; tobacco research : official journal of the Society for Research on Nicotine and Tobacco</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8babb67bdfb4e3b5146a5e5879c9745"><gtr:id>a8babb67bdfb4e3b5146a5e5879c9745</gtr:id><gtr:otherNames>Munaf? MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1462-2203</gtr:issn><gtr:outcomeId>pm_15044_24_22990223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60C20D86-B8C9-4647-A3E1-7A9764A4441E</gtr:id><gtr:title>Genomics. Deflating the genomic bubble.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84b5b6ff0119b9895306d50637892d6b"><gtr:id>84b5b6ff0119b9895306d50637892d6b</gtr:id><gtr:otherNames>Evans JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_15044_24_21330519</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500274</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5841ECCD-C9B1-4B8B-993F-ACC8E9585125</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.1  Primary preventions interventions to modify behaviours or promote well-being</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>